ArticleAnnals of translational medicine2020

FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways.

Cara A Rabik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.